All Pharma News
Vertex inks long-term access deal for CF meds in Englan

Vertex inks long-term access deal for CF meds in Englan
Fraiser Kansteiner FIERCE PHARMA
22 Jun 2024
Share Share
Long-term data shows durability of Vertex`s gene therapy Casgevy

Long-term data shows durability of Vertex`s gene therapy Casgevy
Kevin Dunleavy FIERCE PHARMA
14 Jun 2024
Share Share
Vertex to Participate in Upcoming June Investor Conferences

Vertex to Participate in Upcoming June Investor Conferences
BUSINESSWIRE
22 May 2024
Share Share
Jennifer Schneider Elected to Vertex Board of Directors

Jennifer Schneider Elected to Vertex Board of Directors
BUSINESSWIRE
15 May 2024
Share Share
Tessera unveils promising in vivo gene editing for sickle cell in #ASGCT24

Tessera unveils promising in vivo gene editing for sickle cell in #ASGCT24
Ryan Cross ENDPTS
10 May 2024
Share Share
With 64 centers activated, bluebird is ready to grow Lyfgenia

With 64 centers activated, bluebird is ready to grow Lyfgenia
Kevin Dunleavy FIERCE PHARMA
09 May 2024
Share Share
Vertex touts Casgevy sickle cell launch as bluebird makes progress Lyfgenia

Vertex touts Casgevy sickle cell launch as bluebird makes progress Lyfgenia
ENDPTS
06 May 2024
Share Share
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments

Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
Pratik Jain REUTERS
06 May 2024
Share Share
Vertex Reports First Quarter 2024 Financial Results

Vertex Reports First Quarter 2024 Financial Results
BUSINESSWIRE
06 May 2024
Share Share
Vertex: EU Approval for KALYDECO® in Infants ?1 Month with CF

Vertex: EU Approval for KALYDECO® in Infants ?1 Month with CF
BUSINESSWIRE
26 Apr 2024
Share Share